These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 28605011)

  • 1. Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.
    Lim Z; Wong K; Olson HE; Bergin AM; Downs J; Leonard H
    Epilepsia; 2017 Aug; 58(8):1415-1422. PubMed ID: 28605011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder.
    Lim Z; Wong K; Downs J; Bebbington K; Demarest S; Leonard H
    Epilepsy Res; 2018 Oct; 146():36-40. PubMed ID: 30071384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.
    Kobayashi Y; Tohyama J; Takahashi Y; Goto T; Haginoya K; Inoue T; Kubota M; Fujita H; Honda R; Ito M; Kishimoto K; Nakamura K; Sakai Y; Takanashi JI; Tanaka M; Tanda K; Tominaga K; Yoshioka S; Kato M; Nakashima M; Saitsu H; Matsumoto N
    Brain Dev; 2021 Apr; 43(4):505-514. PubMed ID: 33436160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder.
    Fehr S; Wong K; Chin R; Williams S; de Klerk N; Forbes D; Krishnaraj R; Christodoulou J; Downs J; Leonard H
    Neurology; 2016 Nov; 87(21):2206-2213. PubMed ID: 27770071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study.
    Stenger E; Schaeffer M; Cances C; Motte J; Auvin S; Ville D; Maurey H; Nabbout R; de Saint-Martin A
    Epilepsy Res; 2017 Mar; 131():64-69. PubMed ID: 28273610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges.
    Cervenka MC; Henry BJ; Felton EA; Patton K; Kossoff EH
    Epilepsy Behav; 2016 May; 58():61-8. PubMed ID: 27060389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pragmatic study on efficacy, tolerability and long term acceptance of ketogenic diet therapy in 74 South Indian children with pharmacoresistant epilepsy.
    Baby N; Vinayan KP; Pavithran N; Grace Roy A
    Seizure; 2018 May; 58():41-46. PubMed ID: 29653328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MCT-ketogenic diet as a treatment option in refractory childhood epilepsy: A prospective study with 2-year follow-up.
    Lambrechts DA; de Kinderen RJ; Vles HS; de Louw AJ; Aldenkamp AP; Majoie MJ
    Epilepsy Behav; 2015 Oct; 51():261-6. PubMed ID: 26301622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early-onset epileptic encephalopathy caused by CDKL5 mutation].
    Hjalmgrim H; Hansen LK; Ousager LB; Møller RS
    Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia.
    Hallböök T; Sjölander A; Åmark P; Miranda M; Bjurulf B; Dahlin M
    Eur J Paediatr Neurol; 2015 Jan; 19(1):29-36. PubMed ID: 25457511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cooking oils in a 2:1 ratio classical ketogenic diet for intractable pediatric epilepsy: Long-term effectiveness and tolerability.
    Lee HF; Chi CS; Liao JH
    Epilepsy Res; 2018 Nov; 147():75-79. PubMed ID: 30273790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of low long-term efficacy of antiepileptic drugs and ketogenic diet in 39 patients with CDKL5-related epilepsy.
    Müller A; Helbig I; Jansen C; Bast T; Guerrini R; Jähn J; Muhle H; Auvin S; Korenke GC; Philip S; Keimer R; Striano P; Wolf NI; Püst B; Thiels Ch; Fogarasi A; Waltz S; Kurlemann G; Kovacevic-Preradovic T; Ceulemans B; Schmitt B; Philippi H; Tarquinio D; Buerki S; von Stülpnagel C; Kluger G
    Eur J Paediatr Neurol; 2016 Jan; 20(1):147-51. PubMed ID: 26387070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key clinical features to identify girls with CDKL5 mutations.
    Bahi-Buisson N; Nectoux J; Rosas-Vargas H; Milh M; Boddaert N; Girard B; Cances C; Ville D; Afenjar A; Rio M; Héron D; N'guyen Morel MA; Arzimanoglou A; Philippe C; Jonveaux P; Chelly J; Bienvenu T
    Brain; 2008 Oct; 131(Pt 10):2647-61. PubMed ID: 18790821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ketogenic diet for super-refractory status epilepticus patients in intensive care units.
    Park EG; Lee J; Lee J
    Brain Dev; 2019 May; 41(5):420-427. PubMed ID: 30638692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International Database.
    Wong K; Junaid M; Alexander S; Olson HE; Pestana-Knight EM; Rajaraman RR; Downs J; Leonard H
    CNS Drugs; 2024 Sep; 38(9):719-732. PubMed ID: 39060900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: A single center experience from Turkey.
    Guzel O; Uysal U; Arslan N
    Eur J Paediatr Neurol; 2019 Jan; 23(1):143-151. PubMed ID: 30497921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
    MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
    Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we predict efficacy of the ketogenic diet in children with refractory epilepsy?
    Vehmeijer FO; van der Louw EJ; Arts WF; Catsman-Berrevoets CE; Neuteboom RF
    Eur J Paediatr Neurol; 2015 Nov; 19(6):701-5. PubMed ID: 26206425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy.
    Lambrechts DA; de Kinderen RJ; Vles JS; de Louw AJ; Aldenkamp AP; Majoie HJ
    Acta Neurol Scand; 2017 Feb; 135(2):231-239. PubMed ID: 27027847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ketogenic diet is effective for refractory epilepsy associated with acquired structural epileptic encephalopathy.
    Villaluz MM; Lomax LB; Jadhav T; Cross JH; Scheffer IE
    Dev Med Child Neurol; 2018 Jul; 60(7):718-723. PubMed ID: 29451698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.